toripalimab
B2025-404-01
Phase 3 small_molecule active
Quick answer
toripalimab for Esophageal Cancer is a Phase 3 program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- China SXT Pharmaceuticals
- Indication
- Esophageal Cancer
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active